City

Bethesda (1)

Boston (1)

Houston (1)

Portland (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Phase

phase 1 (2)

early phase 1 (1)

Sponsor

M.D. Anderson Cancer Center (1)

National Cancer Institute (NCI) (1)

OHSU Knight Cancer Institute (1)

Collaborator

National Cancer Institute (NCI) (1)

Oregon Health and Science University (1)

Intervention

atezolizumab (1)

biopsy (1)

cabozantinib s-malate (1)

elimusertib (1)

gemcitabine (1)

nab-paclitaxel (1)

tumor treating fields therapy (1)

wee1 inhibitor zn-c3 (1)

Study Documents

Intervention Type

drug (3)

procedure (2)

biological (1)

Funder Type

Other (2)

NIH (1)

Study Type

Interventional (3)

advanced primary peritoneal carcinoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Fallopian Tube Carcinoma, Advanced Ovarian Carcinoma, Advanced Primary Peritoneal Carcinoma Trial in Portland (Wee1

Not yet recruiting

Advanced Fallopian Tube Carcinoma
+10 more

Wee1 Inhibitor ZN-c3

Portland, Oregon

OHSU Knight Cancer Institute

Jan 25, 2023

Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,

Recruiting

Advanced Fallopian Tube Carcinoma
+21 more

Biopsy
+2 more

Bethesda, Maryland
+2 more

Jan 25, 2023

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting

Advanced Breast Carcinoma
+73 more

Atezolizumab
+3 more

Houston, Texas

M D Anderson Cancer Center

May 5, 2022